The Portland Sea Dogs (38- 66) scored three runs in the first and never looked back, defeating the Binghamton Mets (48-54), 7-0, Thursday night in the Eastern League series opener at NYSEG Stadium.
Nate Freiman led the charge, going 3-for-5 with three RBIs and two doubles. Jalen Beeks (2-2) earned his second Double-A win, working five scoreless frames on two hits and three strikeouts.
Binghamton’s Tyler Pill (8-9) had beaten Portland all four times this year, but the Sea Dogs had his number. Pill yielded eight hits and five runs over five innings.
Freiman gave Portland a 2-0 lead in the first, striking a two-run double to left field. Cody Decker added a run-scoring fielder’s choice.
In the third, Andrew Benintendi
(2-for-4) singled and scored on Freiman’s double to right-center field. Benintendi is tied for the team lead with 22 multi-hit games in just 61 Double-A starts.
Portland added two more in the sixth on an error and an RBI double by Aneury Tavarez (2-for-4, RBI).
Jake Drehoff worked three innings on three hits in relief. Taylor Grover pitched a perfect ninth.
The teams meet again tonight, with first pitch scheduled for 7:05 p.m.
The Sea Dogs return home Tuesday to face the Erie SeaWolves.

Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less